A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence
Clinical trial NCT07087314 · RECRUITING
Trial details
- NCT number
- NCT07087314
- Sponsor
- Mao Jianhua
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2028-07-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.